CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,837,000 | +32.1% | 743,772 | +5.6% | 0.42% | +49.5% |
| Q2 2021 | $8,204,000 | +99.3% | 704,220 | +108.7% | 0.28% | +29.8% |
| Q1 2021 | $4,117,000 | +2.8% | 337,428 | +5.4% | 0.22% | +15.3% |
| Q4 2020 | $4,003,000 | -16.9% | 320,000 | 0.0% | 0.19% | -46.5% |
| Q3 2020 | $4,816,000 | -38.6% | 320,000 | 0.0% | 0.35% | -43.8% |
| Q2 2020 | $7,843,000 | -13.6% | 320,000 | -50.0% | 0.63% | +17.4% |
| Q1 2020 | $9,082,000 | +78.8% | 640,000 | +100.0% | 0.54% | -7.9% |
| Q4 2019 | $5,080,000 | +100.9% | 320,000 | +6.7% | 0.58% | +106.8% |
| Q3 2019 | $2,529,000 | – | 300,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,510,282 | $7,370,000 | 4.76% |
| SANDERS MORRIS HARRIS LLC | 873,021 | $4,261,000 | 0.83% |
| P.A.W. CAPITAL CORP | 150,000 | $732,000 | 0.76% |
| Nantahala Capital Management | 2,244,359 | $10,952,000 | 0.48% |
| Bleichroeder LP | 552,000 | $2,694,000 | 0.48% |
| APOGEM CAPITAL LLC | 111,259 | $543,000 | 0.37% |
| Slate Path Capital LP | 1,483,619 | $7,240,000 | 0.37% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $2,335,000 | 0.20% |
| CARLSON CAPITAL L P | 405,000 | $1,976,000 | 0.14% |
| Bridgefront Capital, LLC | 19,968 | $97,000 | 0.12% |